Blog - Page 2604 of 5707

ThursdayFeb 18, 2016 1:18 pm

Avant Diagnostics (AVDX) Announces a Partnership of Promise with Amarantus Diagnostics

The recent announcement by Avant Diagnostics, Inc (OTCQB: AVDX) and Amarantus Bioscience Holdings, Inc (OTCQX: AMBS) of their intention to tie the knot is a message of cheer for women who may be at risk for ovarian cancer. It also promises a partnership that will aggressively pursue opportunities in the rapidly expanding molecular diagnostics (MDx) market. A summary (http://dtn.fm/w2IbO) of a report from industry consultants Grand View Research estimates global molecular diagnostics market size at over $4.8 billion in 2014 with the U.S. market accounting for over $2.0 billion of that, and, according to a story (http://dtn.fm/D86pl) in The Journal…

ThursdayFeb 18, 2016 10:40 am

Nutra Pharma Corporation (NPHC) Presenting at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference

Before the opening bell, Nutra Pharma Corporation (OTCQB: NPHC) announced that it will present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference, which will take place at The Ritz-Carlton in Miami on South Beach on February 22, 2016. As a presenter, Nutra Pharma will be provided with a 30-minute time slot with which to present to an audience of investors and industry professionals. The company’s management team is also expected to be available for one-on-one meetings with institutional investors attending the event. To view a complete list of presenting companies, visit http://steconference.com/presenting-companies This announcement caps off…

ThursdayFeb 18, 2016 10:03 am

Immune Therapeutics, Inc. (IMUN) Spotlighted in SeeThruEquity Report

On Wednesday, leading independent equity research and corporate access firm SeeThruEquity announced that it has initiated coverage on Immune Therapeutics, Inc. (OTCQB: IMUN) with a 12-month price target of $0.61. IMUN is a specialty pharmaceutical company engaged in the manufacture, distribution and marketing of proprietary therapies targeting chronic, life-threatening diseases through the activation of the body’s immune system. The company’s technology platform includes two unique immunotherapies – Methionine-Enkephalin (MENK) and Low Dose Naltrexone (LDN), which is marketed as Lodonal™. MENK is a revolutionary option of therapy for those diagnosed with various forms of cancer, while LDN, which was originally developed…

ThursdayFeb 18, 2016 9:46 am

OurPet’s Company (OPCO) Targeting $2.5 Billion Market with New Switchgrass Biochar Litter

According to the American Pet Products Association’s 2015-2016 National Survey (http://dtn.fm/0hCVP), there are roughly 86 million pet cats in the United States, up from about 21.5 million in 1970. Across the nearly 43 million American households that currently own a pet cat, one seemingly nondescript product has become virtually ubiquitous – cat litter. Cat litter originally burst onto the scene nearly 70 years ago, according to a report (http://dtn.fm/h8mJR) by The Washington Post, when a man named Ed Lowe repurposed some excess clay into a cleaner alternative to soil or sand, the standard solutions to feline waste in those days.…

WednesdayFeb 17, 2016 4:56 pm

OurPet’s Company (OPCO) Short Sellers Backing Off, Drop by 71%

Short interest in OurPet’s Company (OTCQX: OPCO) has sharply fallen, presumably driven by a host of factors, including word that the specialty pet retailer has several new pet products and strategies on deck. The company’s total short interest was 1,900 shares in February, as reported by FDANewsAlert.com (citing FINRA), a drop of 70.7% from 6,500 shares previously reported. Based on average trading volume of 2,300 shares, the days-to-cover ratio is currently one day. OPCO Tuesday said it will unveil a new product at next month’s Global Pet Expo, sending shares up nearly 11% to an intraday high of $0.89 on…

WednesdayFeb 17, 2016 4:32 pm

International Stem Cell Corp. (ISCO) Provides Hope for Parkinson’s Patients with Ethical Stem Cell Development

Parkinson’s disease is caused by death of dopamine-producing cells in a brain region called the substantia nigra, which hampers movement. Current treatments focus primarily on replacing the lost dopamine, but these treatments eventually fail because the dopamine-making cells continue to die. For this reason, stem cell therapy is of interest. International Stem Cell Corporation (OTCQB: ISCO) is a biotechnology company that focuses on the development of therapeutic and biomedical products worldwide. The company’s products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cells. International Stem Cell Corp. develops cell types, including neural stem cells, for…

WednesdayFeb 17, 2016 2:38 pm

GTX Corp. (GTXO) Has You Covered 24/7 with Expert GPS Monitoring Technology

GTX Corp. (OTC: GTXO) stands at the forefront of wearable GPS technology while being a leader in two-way personal location services. Headquartered in Los Angeles, the company shows off its knowledge of miniaturized and low-power consumption GPS, BLE, and cellular tracking solutions. GTXO has distributors in 13 countries that send-off customizable solutions like hardware, apps, and connectivity services to valued customers. GTXO promises real-time location and monitoring solutions that are on call 24/7. These solutions are specially made to track people, pets, vehicles, and high-end assets. Through its many devices, customers can track and receive updates constantly via a data…

WednesdayFeb 17, 2016 9:52 am

Star Mountain Resources, Inc. (SMRS) Building Growth-Based Foundation Ahead of Rallying Zinc Prices

Star Mountain Resources, Inc. (OTC: SMRS) is a microcap mining company that builds shareholder value by way of acquiring and developing mineral properties and turning them into major producing mines. SMRS’s growth plan uses this acquisition model as its guide. Currently, Star Mountain Resources is busy developing operations to restart its Balmat zinc mining operation in St. Lawrence County, New York. Operations are aimed at transforming the company into an active mining producer rather than a junior explorer. In the fourth quarter of 2015, the company acquired Northern Zinc, LLC, a private company, and closed on the acquisition of the…

TuesdayFeb 16, 2016 3:43 pm

Nutra Pharma Corp. (NPHC) Relieving Wisdom Tooth Pain the All Natural Way

Wisdom teeth are an oxymoron. Why would someone label something that has no real value and brings nothing but pain with ‘wisdom’? Almost everyone eventually has to have one to all four of their wisdom teeth removed, which is followed immediately by a long bout of pain and discomfort. In addition to the rounds of antibiotics that are typically prescribed to prevent infection, narcotic pain medications are also prescribed, which can lead to habit-forming tendencies. Nutra Pharma Corporation (OTCQB: NPHC) markets pharmaceuticals for the treatment of pain under the brand Nyloxin® and also has a product for pets under the…

TuesdayFeb 16, 2016 2:08 pm

FlexWeek, Inc. (FXWK) Takes the Sting Out of Unused Timeshare Expenses

At the forefront of the peer-to-peer (P2P) vacation-home marketplace sits FlexWeek, Inc. (OTC: FXWK). Being the first of its kind, the company offers a platform for timeshare owners to market their unused vacation time to the public or other timeshare owners. FlexWeek provides direct access to its resort inventory while eliminating the need for timeshare owners to use other expensive trading platforms. The company charges booking fees to the renter of the vacation time instead of “banking” times with a trading company. This means that the private timeshare owner can offer his/her unused vacation time to renters to recoup the…

Site Search

Company Search